Kimura and colleagues demonstrated by in vitro experiments that exosomes circulating in MS patients were able to reduce the relative frequency of IFN-γ−IL-17A−Foxp3+CD4+ T cells, regarded as most suppressive Treg cells. Here, CD4 is linked to myeloid sarcoma.